Registration Statement · S-1
BIOVENTRIX, INC.
BVXXNASDAQEQUITYCurrent
Registration Statement
Company context
We are a medical device company focused on developing, manufacturing and commercializing proprietary devices to restore left ventricular function in heart failure patients with reduced ejection fraction (“HFrEF”).
Current securities
As-filed source
As filedOpen full document ↗